八九十岁高龄患者脑肿瘤手术安全性:单术者741例系列
该回顾性队列研究纳入单神经外科医生连续手术的741例脑肿瘤患者,分为青年组(20-29岁,88例)、老年组(60-79岁,570例)和高龄组(80岁及以上,83例)。比较术前术后改良Rankin评分变化(ΔmRS)、住院时长、并发症率和30天再入院率,结果显示高龄组与年轻组无显著差异。结论认为,在健康患者中,仅高龄本身不应成为拒绝脑肿瘤手术的理由。
要点
- 高龄组(80+)并发症率6.0%,与青年组4.5%和老年组7.2%无显著差异。
- 高龄组住院时长1.93±0.176天,与青年组和老年组无显著差异。
- 统计等效性检验显示各年龄组ΔmRS具有等效性(95%置信度)。
核心结论
- 高龄患者脑肿瘤手术后ΔmRS、住院时长、30天再入院率和并发症率与年轻患者无显著差异。
- 在健康患者中,仅高龄本身不应阻止患者接受脑肿瘤手术。
研究设计与样本
- 回顾性队列研究,纳入单神经外科医生手术的741例脑肿瘤患者。
- 分组:青年组(20-29岁,88例)、老年组(60-79岁,570例)、高龄组(80岁及以上,83例)。
主要发现
- 各组术前mRS无显著差异(χ²=0.269,P=0.874)。
- 高龄组并发症率6.0%,与青年组4.5%(P=0.667)和老年组7.2%(P=0.696)无显著差异。
- 高龄组住院时长1.93±SD 0.176天,与青年组3.01±0.384天(P=0.081)和老年组2.47±0.144天(P=0.881)无显著差异。
- 统计等效性检验显示各年龄组ΔmRS在95%置信度下具有等效性。
临床怎么用
- 对于健康的高龄(80岁及以上)脑肿瘤患者,不应仅因年龄因素拒绝提供手术。
局限性
- 本研究为单术者回顾性队列研究,结果可能受术者经验及患者选择偏倚影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Elderly patients with surgically accessible brain tumors are often not offered clinically indicated brain tumor surgery (BTS) because of to assumptions of greater risk for perioperative morbidity and mortality. Because brain tumor incidence is highest in the geriatric population, and because the global population is aging, accurate understanding of BTS risk in elderly patients is critical. We aimed to compare safety of BTS in elderly patients with younger counterparts to better understand the risk-benefit profile of BTS for elderly patients. METHODS: Retrospective cohort study of young (20-29 years), senior (60-79 years), and elderly (80+ years) patients who underwent BTS with a single neurosurgeon. Differences between pre- and postoperative modified Rankin score (ΔmRS), length of hospitalization (LOH), complication rate, and 30-day readmission rates (30DRR) were recorded. RESULTS: A total of 741 patients (83 elderly, 570 senior, and 88 young) were identified. No significant difference in preoperative mRS between different age groups, χ2 = 0.269, P = 0.874. Elderly complication rate was 6.0%, not significantly different from young (4.5%, P = 0.667) or senior (7.2%, P = 0.696) complication rate. Elderly LOH was 1.93 ± SD 0.176 days; not significantly different from young (3.01 ± 0.384 days, P = 0.081) or senior (2.47 ± 0.144 days, P = 0.881). Statistical equivalence testing showed with 95% confidence that there was equivalence in ΔmRS among age groups. CONCLUSIONS: Elderly patients did not have significantly different ΔmRS, LOH, 30DRR, or complication rates after BTS compared with younger counterparts. Therefore, in healthy patients, advanced age alone should not prevent patients from being offered BTS.
引用
- Eichberg DG, Di L, Shah AH, et al. Brain Tumor Surgery is Safe in Octogenarians and Nonagenarians: A Single-Surgeon 741 Patient Series. World Neurosurg. 2019. PMID: 31505286. doi:10.1016/j.wneu.2019.08.219
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。